A BILL 
To substantially restrict the use of animal testing for 
cosmetics. 
17:08 Dec 17, 2021
H6207
2 
•HR 6207 IH
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Humane Cosmetics 
4
Act of 2021’’. 
5
SEC. 2. ANIMAL TESTING. 
6
(a) PROHIBITION ON ANIMAL TESTING.—Beginning 
7
on the date that is 1 year after the date of enactment 
8
of this Act, it shall be unlawful for any person, whether 
9
private or governmental, to knowingly conduct or contract 
10
for cosmetic animal testing that occurs in the United 
11
States. 
12
(b) PROHIBITION ON SALE OR TRANSPORT.—Begin-
13
ning on the date that is 1 year after the date of enactment 
14
of this Act, it shall be unlawful to sell, offer for sale, or 
15
knowingly transport in interstate commerce in the United 
16
States any cosmetic product that was developed or manu-
17
factured using cosmetic animal testing that was conducted 
18
or contracted for by any person in the cosmetic product’s 
19
supply chain after such date. 
20
(c) DATA USE.— 
21
(1) IN
GENERAL.—No evidence derived from 
22
animal testing conducted after the effective date 
23
specified in subsection (a) may be relied upon to es-
24
tablish the safety of a cosmetic, cosmetic ingredient, 
25
17:08 Dec 17, 2021
H6207
3 
•HR 6207 IH
or nonfunctional constituent under the Federal 
1
Food, Drug, and Cosmetic Act (21 U.S.C. 301 et 
2
seq.), unless— 
3
(A) in the case of such testing on an ingre-
4
dient or nonfunctional constituent, there is no 
5
non-animal alternative method or strategy rec-
6
ognized by any Federal agency, the Interagency 
7
Coordinating Committee on the Validation of 
8
Alternative Methods, or the Organisation for 
9
Economic Co-operation and Development for 
10
the relevant safety endpoints for such ingre-
11
dient or nonfunctional constituent; and 
12
(B)(i) such animal testing is subject to an 
13
exemption under paragraph (2) or (3) of sub-
14
section (d); or 
15
(ii)(I) such animal testing is subject to an 
16
exemption under paragraph (4) of subsection 
17
(d); 
18
(II) there is documented evidence of the 
19
non-cosmetic intent of the test; and 
20
(III) there is a history of use of the ingre-
21
dient outside of cosmetics at least 1 year prior 
22
to the reliance on such data. 
23
(2) LIMITATION.—This section shall not be con-
24
strued to prohibit any entity from reviewing, assess-
25
17:08 Dec 17, 2021
H6207
4 
•HR 6207 IH
ing, or retaining evidence generated from animal 
1
testing. 
2
(d) EXEMPTIONS.—Subsections (a) and (b) shall not 
3
apply with respect to animal testing— 
4
(1) conducted outside the United States in 
5
order to comply with a requirement from a foreign 
6
regulatory authority; 
7
(2) requested, required, or conducted by the 
8
Secretary, following— 
9
(A) a written finding by the Secretary 
10
that— 
11
(i) there is no non-animal alternative 
12
method or strategy recognized by any Fed-
13
eral agency, the Interagency Coordinating 
14
Committee on the Validation of Alternative 
15
Methods, or the Organisation for Economic 
16
Co-operation and Development for the rel-
17
evant safety endpoints for the cosmetic in-
18
gredient or nonfunctional constituent; 
19
(ii) there is a reasonable probability 
20
that the ingredient or nonfunctional con-
21
stituent poses a specific and serious ad-
22
verse human health risk and the need to 
23
conduct an animal test is justified and 
24
supported by a detailed research protocol 
25
17:08 Dec 17, 2021
H6207
5 
•HR 6207 IH
that is proposed for the basis for evalua-
1
tion of the cosmetic ingredient or nonfunc-
2
tional constituent; and 
3
(iii) the cosmetic ingredient or non-
4
functional constituent is in wide use and, 
5
in the case of a cosmetic ingredient, cannot 
6
be replaced by another cosmetic ingredient 
7
capable of performing a similar function; 
8
(B) publication by the Secretary, on the 
9
website of the Food and Drug Administration, 
10
of the written finding under subparagraph (A) 
11
together with a notice that the Secretary in-
12
tends to request, require, or conduct new ani-
13
mal testing, and providing a period of not less 
14
than 60 calendar days for public comment; and 
15
(C) a written determination by the Sec-
16
retary, after review of all public comments re-
17
ceived pursuant to subparagraph (B), that no 
18
previously generated data that could be sub-
19
stituted for, or otherwise determined sufficient 
20
to replace, the data expected to be produced 
21
through new animal testing is available for re-
22
view by the Secretary; 
23
(3) conducted for any product or ingredient 
24
that is subject to regulation under chapter V of the 
25
17:08 Dec 17, 2021
H6207
6 
•HR 6207 IH
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
1
351 et seq.); or 
2
(4) conducted for non-cosmetic purposes pursu-
3
ant to a requirement of a Federal, State, or foreign 
4
regulatory authority. 
5
(e) RULE OF CONSTRUCTION.—With the exception of 
6
records or other information demonstrating compliance 
7
with subsection (c)(1)(B)(ii), nothing in this section shall 
8
be construed to authorize the Secretary to impose any new 
9
recordkeeping requirements relating to cosmetic animal 
10
testing. 
11
(f) CIVIL PENALTIES.— 
12
(1) IN
GENERAL.—In addition to any other 
13
penalties under applicable law, any person who vio-
14
lates this section may be subject to a civil penalty 
15
in an amount of not more than $10,000 for each 
16
such violation, as determined by the Secretary. 
17
(2) MULTIPLE VIOLATIONS.—Each violation of 
18
this section with respect to a separate animal, and 
19
each day that a violation of this Act continues, con-
20
stitutes a separate offense. 
21
(g) RECORDS ACCESS.— 
22
(1) IN GENERAL.—The Secretary may request 
23
any records or other information from a cosmetic 
24
manufacturer that such manufacturer relied upon to 
25
17:08 Dec 17, 2021
H6207
7 
•HR 6207 IH
meet the criteria in subsection (c)(1)(B)(ii). Such 
1
manufacturer shall, upon such request of the Sec-
2
retary in writing, provide to the Secretary such 
3
records or other information, within a reasonable 
4
timeframe, within reasonable limits, and in a reason-
5
able manner, and in either electronic or physical 
6
form, at the expense of such manufacturer. The Sec-
7
retary’s request shall include a sufficient description 
8
of the records requested and reference this sub-
9
section. 
10
(2) CONFIRMATION OF RECEIPT.—Upon receipt 
11
of the records requested under paragraph (1), the 
12
Secretary shall provide to the manufacturer con-
13
firmation of receipt. 
14
(3) INSPECTION AUTHORITY.—Nothing in this 
15
subsection supplants the authority of the Secretary 
16
to conduct inspections otherwise permitted under the 
17
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
18
301 et seq.). 
19
(h) STATE AUTHORITY.—No State or political sub-
20
division of a State may establish or continue in effect any 
21
prohibition relating to cosmetic animal testing, or to the 
22
regulation of data use, labeling, and packaging related to 
23
animal testing, that is not identical to the prohibitions set 
24
forth in subsections (a), (b), (c), and (j) and that does 
25
17:08 Dec 17, 2021
H6207
8 
•HR 6207 IH
not include the exemptions contained in subsections (c), 
1
(d), and (j). No State or political subdivision of a State 
2
may require any entity to perform cosmetic animal testing 
3
that is not permitted by subsection (a). 
4
(i) FDA STRATEGIC PLAN FOR NON-ANIMAL TEST 
5
METHODS.— 
6
(1) SCIENTIFIC INNOVATION.—To promote the 
7
development of, and provide for expedited review and 
8
acceptance of, new scientifically valid test methods 
9
and strategies that are not based on vertebrate ani-
10
mals, the Secretary shall— 
11
(A) not later than 1 year after the date of 
12
enactment of this Act, develop and publish on 
13
the website of the Food and Drug Administra-
14
tion a strategic plan to promote the develop-
15
ment and implementation of alternative test 
16
methods and strategies to replace vertebrate 
17
animal testing for assessing the safety of cos-
18
metics; 
19
(B) provide a period of not less than 60 
20
calendar days for public comment regarding 
21
such strategic plan; 
22
(C) include in the strategic plan developed 
23
under subparagraph (A) a list (which the Sec-
24
retary shall update on a regular basis, and 
25
17:08 Dec 17, 2021
H6207
9 
•HR 6207 IH
which shall be for informational purposes and 
1
shall not be deemed to constitute a list of the 
2
only acceptable non-animal test methods) of— 
3
(i) scientifically reliable and relevant 
4
non-animal test methodology as alter-
5
natives to animal testing that have been 
6
recognized by any Federal agency or an 
7
international regulatory agency; 
8
(ii) next generation risk assessment 
9
methods; and 
10
(iii) examples of alternative methods 
11
and strategies that have been accepted by 
12
the Secretary; and 
13
(D) to the maximum extent practicable 
14
given available resources, prioritize and carry 
15
out performance assessment, validation, and 
16
translational studies to accelerate the develop-
17
ment of scientifically valid test methods and 
18
strategies that replace the use of vertebrate ani-
19
mals. 
20
(2) PUBLIC MEETINGS.— 
21
(A) INITIAL MEETING.—Not later than 90 
22
days after the date of enactment of this Act, 
23
the Secretary shall convene a public meeting re-
24
17:08 Dec 17, 2021
H6207
10 
•HR 6207 IH
garding the strategic plan described in para-
1
graph (1)(A). 
2
(B) SUBSEQUENT
ANNUAL
MEETINGS.— 
3
Not later than 1 year after the date of the pub-
4
lic meeting under subparagraph (A), and annu-
5
ally thereafter, the Secretary shall convene a 
6
separate public meeting or add as an agenda 
7
item to an already existing meeting, in-person 
8
or virtually, to inform the Secretary’s advance-
9
ment of alternative test methods and strategies 
10
to replace vertebrate animal testing for assess-
11
ing the safety of cosmetics. The Secretary shall 
12
include in such meetings scientific and aca-
13
demic experts, animal and consumer advocacy 
14
groups, and the regulated industry. 
15
(3) RULE OF CONSTRUCTION.—Nothing in this 
16
subsection shall be construed to limit the authority 
17
of the Secretary to address other tools to promote 
18
the development and implementation of alternative 
19
test methods and strategies to replace vertebrate 
20
animal testing for assessing the safety of cosmetics 
21
as part of the strategic plan described in paragraph 
22
(1)(A). 
23
(j) CONSUMER INFORMATION RELATED TO ANIMAL 
24
TESTING.— 
25
17:08 Dec 17, 2021
H6207
11 
•HR 6207 IH
(1) IN GENERAL.—A cosmetic product manu-
1
facturer shall not include on the label of a cosmetic 
2
product or any of the product’s containers or wrap-
3
pers a claim that such cosmetic product was not 
4
tested on animals, including any claim or logo of 
5
‘‘cruelty free’’ if— 
6
(A) such cosmetic product or any ingre-
7
dient or nonfunctional constituent contained in 
8
such cosmetic product was tested on an animal 
9
after the effective date specified in subsection 
10
(a); and 
11
(B)(i) the testing was conducted by or con-
12
tracted for by the cosmetic product manufac-
13
turer or another person in the supply chain at 
14
the direction or request of the cosmetic product 
15
manufacturer; or 
16
(ii) the cosmetic product manufacturer re-
17
lied upon evidence from such testing, pursuant 
18
to subsection (c)(1)(B)(ii), to establish the safe-
19
ty of such product, ingredient, or nonfunctional 
20
constituent under chapter VI of the Federal 
21
Food, Drug, and Cosmetic Act (21 U.S.C. 361 
22
et seq.). 
23
(2) EXCEPTIONS.—Notwithstanding paragraph 
24
(1), a cosmetic product manufacturer may include a 
25
17:08 Dec 17, 2021
H6207
12 
•HR 6207 IH
claim described in such paragraph on the label of a 
1
cosmetic product described in such paragraph or any 
2
of the product’s containers or wrappers if— 
3
(A) such testing qualifies for the exemp-
4
tion under subsection (d)(4); and 
5
(B)(i) in the case of animal testing con-
6
ducted by or contracted for by the cosmetic 
7
product manufacturer or another person in the 
8
supply chain at the direction or request of the 
9
cosmetic product manufacturer, the cosmetic 
10
manufacturer did not rely upon evidence from 
11
such testing for the purpose of establishing the 
12
safety of the product, ingredient, or nonfunc-
13
tional constituent under chapter VI of the Fed-
14
eral Food, Drug, and Cosmetic Act (21 U.S.C. 
15
361 et seq.); or 
16
(ii) in the case of animal testing conducted 
17
by or contracted for by a person that is not de-
18
scribed in clause (i), evidence from which the 
19
cosmetic product manufacturer relied upon, 
20
pursuant to subsection (c)(1)(B)(ii), to estab-
21
lish the safety of such product, ingredient, or 
22
nonfunctional constituent under chapter VI of 
23
the Federal Food, Drug, and Cosmetic Act (21 
24
U.S.C. 361 et seq.), the cosmetic product man-
25
17:08 Dec 17, 2021
H6207
13 
•HR 6207 IH
ufacturer includes on the label a disclosure de-
1
scribing the circumstances surrounding the use 
2
of the exemption under subsection (c)(1)(B)(ii) 
3
by such manufacturer that includes a reference 
4
to the specific Federal, State, or foreign re-
5
quirement under which the animal testing was 
6
conducted or a reference to a publicly available 
7
internet website of such manufacturer that pro-
8
vides such disclosure. 
9
(k) REPORT.—Beginning 2 years after the date of en-
10
actment of this Act, the Secretary shall biennially submit 
11
to the Committee on Health, Education, Labor, and Pen-
12
sions of the Senate and the Committee on Energy and 
13
Commerce of the House of Representatives, and make 
14
available on the website of the Food and Drug Administra-
15
tion, a report that includes, with respect to the previous 
16
2 fiscal years— 
17
(1) updates on the Secretary’s implementation 
18
of this section, including developments implementing 
19
the strategic plan under subsection (i)(1)(A); 
20
(2) the number of times the Secretary re-
21
quested animal test data under subsection (d)(2), 
22
the ingredients involved, and the animal tests per-
23
formed; and 
24
17:08 Dec 17, 2021
H6207
14 
•HR 6207 IH
(3) based on the data reviewed by the Secretary 
1
under subsection (g)(1), the number of times manu-
2
facturers relied upon data pursuant to the exemp-
3
tion under subsection (d)(4) to establish the safety 
4
of a cosmetic under chapter VI of the Federal Food, 
5
Drug, and Cosmetic Act (21 U.S.C. 361 et seq.). 
6
(l) DEFINITIONS.— 
7
(1) COSMETIC.—The term ‘‘cosmetic’’ has the 
8
meaning given such term in section 201(i) of the 
9
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
10
321(i)). 
11
(2) COSMETIC
ANIMAL
TESTING.—The term 
12
‘‘cosmetic animal testing’’ means the internal or ex-
13
ternal application or exposure of any cosmetic prod-
14
uct, or any cosmetic ingredient or nonfunctional con-
15
stituent, to the skin, eyes, or other body part (organ 
16
or extremity) of a live non-human vertebrate for the 
17
purpose of evaluating the safety or efficacy of a cos-
18
metic product or a cosmetic ingredient or nonfunc-
19
tional constituent for use in a cosmetic product. 
20
(3) LABEL.—The term ‘‘label’’ has the meaning 
21
given such term in section 201(k) of the Federal 
22
Food, Drug, and Cosmetic Act (21 U.S.C. 321(k)). 
23
(4) NONFUNCTIONAL CONSTITUENT.—The term 
24
‘‘nonfunctional constituent’’ means any incidental in-
25
17:08 Dec 17, 2021
H6207
15 
•HR 6207 IH
gredient as defined in section 701.3(l) of title 21, 
1
Code of Federal Regulations, on the date of enact-
2
ment of this section. 
3
(5) SECRETARY.—The term ‘‘Secretary’’ means 
4
the Secretary of Health and Human Services. 
5
Æ 
17:08 Dec 17, 2021
H6207
